Personalized Medicine: Using Psychogenomic Testing in Your Practice - PDF document

APNA 30th Annual Conference Session 2045: October 20, 2016 Personalized Medicine: Using Psychogenomic Testing in Your Practice Sheryl LaCoursiere, PhD, PMHNP ‐ BC, FNP ‐ BC, APRN University of Massachusetts Boston College of Nursing and Health Sciences Disclosure • The presenter has no conflicts of interest to disclose. Objectives • Participants will describe three common methods of selecting psychiatric medications in practice. • Learners will identify three studies related to psychogenomic testing. • Learners will discuss three disadvantages of psychogenomic testing. LaCoursiere 1

APNA 30th Annual Conference Session 2045: October 20, 2016 Methods of Selecting Psychiatric Medications • Drug Class • Patient History • Family History • Psychogenomic Testing Studies on Pharmacogenomic Testing • Altar et al., 2015 • Winner et al., 2015 • Hall ‐ Flavinet et al., 2013 • Winner et al., 2013 Results ‐ GeneSight LaCoursiere 2

APNA 30th Annual Conference Session 2045: October 20, 2016 Results ‐ Genomind Ways to Use Pharmacogenomics in Your Practice Determine if testing is a right fit for the patient • Insurance coverage • Cost/benefit analysis • Patient psychiatric drug naivete Ways to Use Pharmacogenomics in Your Practice (cont’d) • Use of testing to rule out/rule in potentially efficacious medications • Determining a "short list" of medications to try • Offering the patient hope • Implications for the future LaCoursiere 3

APNA 30th Annual Conference Session 2045: October 20, 2016 Ques Questions? tions? sheryl.lacoursiere@umb.edu LaCoursiere 4